ARCHIVES

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 09 | March 7, 2008

Download PDF Visit The Full Archive

Related Articles

No Justification Provided: DePinho’s Nixing of Tenure Renewals May Bring Censure to MD Anderson

April 25, 2014

Protest Erupts Over Charge That NCAB Directives On CCOP Are Ignored; “Misunderstanding,” DeVita Says

June 25, 1982

Propac To Recommend Reclassification Of Five Leukemia/Lymphoma Diagnosis Related Groups

March 21, 1986

Mouse Strains Now Available From NCI

March 18, 1983

Cancer Letter, PR Firm Settle Out Of Court On Copyright Violation

November 27, 1987

AACR, ASCO, ONS Flex Political Muscles, Seek Changes In Cancer Act, Other Legislation, Funding Of Grants

May 7, 1982